Affordable Access

Publisher Website

Do antidepressants regulate how cortisol affects the brain?

Publication Date
DOI: 10.1016/j.psyneuen.2003.10.009
  • Antidepressant
  • Glucocorticoid Receptor
  • Hypothalamic–Pituitary–Adrenal Axis
  • Mineralocorticoid Receptor
  • Multidrug Resistance
  • P-Glycoprotein
  • Biology
  • Chemistry
  • Medicine


Abstract Although the effects of antidepressants on glucocorticoid hormones and their receptors are relevant for the therapeutic action of these drugs, the molecular mechanisms underlying these effects are unclear. Studies in depressed patients, animals and cellular models have demonstrated that antidepressants increase glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) expression and function; this, in turn, is associated with enhanced negative feedback by endogenous glucocorticoids, and thus with reduced resting and stimulated hypothalamic–pituitary–adrenal (HPA) axis activity. In a series of studies conducted over the last few years, we have shown that antidepressants modulate GR function in vitro by inhibiting membrane steroid transporters that regulate the intracellular concentration of glucocorticoids. In this paper, we will review the effects of membrane steroid transporters and antidepressants on corticosteroid receptors. We will then present our unpublished data on GR live microscopy in vitro, showing that ligand-induced translocation of the GR starts within 30 seconds and is completed within minutes. Furthermore, we will present our new data using an in situ brain perfusion model in anaesthetised guinea-pigs, showing that entry of cortisol to the brain of these animals is limited at the blood–brain barrier (BBB). Finally, we will present a comprehensive discussion of our published findings on the effects of chemically unrelated antidepressants on membrane steroid transporters, in mouse fibroblasts and rat cortical neurones. We propose that antidepressants in humans could inhibit steroid transporters localised on the BBB and in neurones, like the multidrug resistance p-glycoprotein, and thus increase the access of cortisol to the brain and the glucocorticoid-mediated negative feedback on the HPA axis. Enhanced cortisol action in the brain might prove to be a successful approach to maximise therapeutic antidepressant effects.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Do antidepressants regulate how cortisol affects t...

on Psychoneuroendocrinology May 2004

How does the brain regulate negative bias to stigm...

on Social cognitive and affective... August 2012

How do antidepressants work?

on Molecular medicine today December 1995
More articles like this..